Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

311.53
-1.7750-0.57%
Volume:90.24K
Turnover:28.16M
Market Cap:18.75B
PE:33.82
High:313.91
Open:312.91
Low:311.17
Close:313.30
52wk High:330.75
52wk Low:249.57
Shares:60.18M
Float Shares:60.18M
Volume Ratio:0.69
T/O Rate:0.15%
Dividend:4.73
Dividend Rate:1.52%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.95
PE(LYR):7.51

Loading ...

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Reuters
·
Sep 09

Headlands Research Names Brandon Pallott Chief Commercial Officer

Reuters
·
Sep 09

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

TIPRANKS
·
Sep 09

ABL Diagnostics Delivers Surging Profits as Scale‑Up Strategy Takes Hold

TIPRANKS
·
Sep 09

Option traders moderately bearish in UnitedHealth with shares down 1.28%

TIPRANKS
·
Sep 08

Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Dow Jones
·
Sep 08

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Amid Rising Oil Prices

MT Newswires Live
·
Sep 08

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

GlobeNewswire
·
Sep 08

Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai

Reuters
·
Sep 08

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

GlobeNewswire
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 08

TEDA BIOMEDICAL Joins Forces with Xingchen Universal to Accelerate Embodied AI in Healthcare

Stock News
·
Sep 08

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live
·
Sep 08

Bluejay Diagnostics and Lovell Government partner to access federal healthcare

TIPRANKS
·
Sep 08

Abbvie : Bofa Global Research Raises Price Objective to $282.00 from $276.00

THOMSON REUTERS
·
Sep 08

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

TIPRANKS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

TIPRANKS
·
Sep 08